ADIAL PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.69 USD | +4.97% |
|
-11.05% | -9.14% |
| Apr. 22 | Adial Pharmaceuticals Granted US Patent for Genetic Diagnostic, AD04 Combination to Treat Alcohol Use Disorder | MT |
| Apr. 12 | Top Premarket Decliners | MT |
Chart calendar Adial Pharmaceuticals, Inc.
dbd67a8d20c5038.TjC35fSydF-gVS-ijQbTF5_euF48Elhmo8tmEv4C94k.Cn7aoZDGRjzRIF7P93_iQNmX7zB0ewc_9vghXZxHlcgIduiWkNcaFpE_QA~a0e01c5f4c0cd1e28cefe01df0d26a0f
Upcoming events on Adial Pharmaceuticals, Inc.
Past events on Adial Pharmaceuticals, Inc.
| 2024-02-20 11:30 am | Winter Wrap-Up MicroCap Rodeo Conference |
| 2023-11-14 05:02 pm | Q3 2023 Earnings Release |
| 2023-11-03 05:30 am | International Society of Addiction Medicine Conference |
| 2023-10-25 10:30 am | Fall Foliage MicroCap Rodeo Conference |
| 2023-10-04 02:15 pm | Investor Meeting - Key Opinion Leader |
| 2023-09-11 07:00 am | H.C. Wainwright Global Investment Conference |
| 2023-06-09 12:15 pm | Jefferies Global Healthcare Conference |
| 2023-05-12 08:30 am | Q1 2023 Earnings Release |
| 2023-03-30 04:05 pm | Q4 2022 Earnings Release |
| 2023-03-14 03:00 pm | Roth Conference |
| 2023-03-07 08:15 am | Business Update Call |
| 2022-11-14 08:30 am | Q3 2022 Earnings Release |
| 2022-08-23 08:30 am | Business Update Call |
| 2022-08-16 09:15 am | Interim 2022 Earnings Release |
| 2022-07-20 01:00 pm | AD04 Onward™ Phase 3 Trial Results Call |
| 2022-05-16 09:25 am | Interim 2022 Earnings Release |
| 2022-03-28 11:30 am | Maxim Group Virtual Growth Conference |
| 2022-01-10 07:00 am | H.C. Wainwright BioConnect Conference |
| 2021-11-18 11:00 am | Business Update Call |
| 2021-10-21 09:45 am | Dawson James Securities Small Cap Growth Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -8,24 -8,05 -2.38% | -10,9 -10,9 -0.23% | -19,3 -17,6 -9.78% | -13,3 -14,1 5.48% | -6,89 -6,97 1.15% | -6,48 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -8,59 -8,43 -1.89% | -10,9 -10,9 -0.22% | -19,5 -17,9 -9.31% | -12,7 -13,9 8.24% | -7,00 -6,72 -4.19% | -6,46 |
|
Net income Million USD | Released Forecast Spread | -8,59 -8,43 -1.89% | -10,9 -10,9 -0.22% | -19,4 -17,9 -8.79% | -12,7 -13,9 8.25% | -5,12 -6,72 23.77% | -6,46 |
|
EPS USD | Released Forecast Spread | -21,8 -21,8 0% | -21,8 -22,3 2.25% | -26,0 -24,0 -8.33% | -12,8 -14,0 8.93% | -3,60 -5,46 34.07% | -1,99 |
| Announcement Date | 20/03/20 | 22/03/21 | 28/03/22 | 30/03/23 | 01/04/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -5,98 -4,26 -40.32% | -3,06 -4,00 23.53% | -3,83 -3,77 -1.5% | -3,19 -4,41 27.67% | -3,24 -4,01 19.24% | -2,92 -4,00 26.98% | -1,48 -2,65 44.25% | -1,36 -1,30 -4.46% | -1,78 -1,21 -47.12% | -1,51 | -1,51 | -1,59 | -1,59 | -1,55 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -5,92 -4,26 -39.02% | -2,91 -4,00 27.32% | -3,85 -3,77 -1.98% | -3,11 -4,41 29.44% | -2,87 -4,01 28.52% | -2,91 -4,00 27.37% | -1,51 -2,65 43.05% | -1,35 -1,29 -4.23% | -1,90 -1,01 -88.56% | -1,40 | -1,40 | -1,55 | -1,55 | -1,55 |
|
Net income Million USD | Released Forecast Spread | -5,83 -4,26 -36.81% | -2,91 -4,00 27.32% | -3,85 -3,77 -1.98% | -3,11 -4,41 29.44% | -2,87 -4,01 28.53% | -2,91 -4,00 27.37% | 1,09 -2,65 141.03% | -1,40 -1,29 -8.28% | -1,92 -1,01 -90.13% | -1,40 | -1,40 | -1,55 | -1,55 | -1,55 |
|
EPS USD | Released Forecast Spread | -7,00 -5,17 -35.48% | -3,25 -4,25 23.53% | -4,00 -3,67 -9.09% | -3,00 -4,50 33.33% | -2,75 -3,83 28.26% | -2,75 -3,50 21.43% | 0,96 -2,25 142.67% | -1,18 -1,14 -3.96% | -0,74 -0,63 -17.46% | -0,33 | -0,33 | -0,35 | -0,34 | -0,34 |
| Announcement Date | 28/03/22 | 16/05/22 | 15/08/22 | 14/11/22 | 30/03/23 | 12/05/23 | 21/08/23 | 14/11/23 | 01/04/24 | - | - | - | - | - |
| Today 04:05 pm | EXELIXIS, INC.: Q1 2024 Earnings Release |
| 2024-04-30 | SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release |
| 2024-04-30 | MACROGENICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | REGENXBIO INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | DECIPHERA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-01 07:00 am | NEUROCRINE BIOSCIENCES, INC.: Q1 2024 Earnings Release |
| 2024-05-01 04:05 pm | SAREPTA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-01 | ZENTALIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-01 | DENALI THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-01 | GERON CORPORATION: Q1 2024 Earnings Release |
Past sector events for Adial Pharmaceuticals, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ADIL Stock
- Calendar Adial Pharmaceuticals, Inc.
